论文信息 - The potent small molecule integrin antagonist THR‐687 is a promising next‐generation therapy for retinal vascular disorders - 字舞流文

The potent small molecule integrin antagonist THR‐687 is a promising next‐generation therapy for retinal vascular disorders

M. Vanhove | Michaël Porcu | J. Feyen | B. Jonckx | T. Van Bergen | T. Hu | I. van Hove | E. Vermassen | P. Barbeaux | Elke Vermassen | Philippe Barbeaux